Screen: 16
Covariate | bRFS: HR [95% CI] | MFS: HR [95% CI] |
Gleason Grade | 1.11 [0.94-1.31] | 1.38 [1.08-1.75] |
Nodal involvement | 1.29 [0.64-2.61] | 1.20 [0.47-3.05] |
Seminal vesicle invasion | 1.61 [1.03-2.53] | 1.59 [0.88-2.88] |
ADT | 0.41 [0.24-0.69] | 0.91 [0.50-1.68] |
Pre-SRT PSA | 1.10 [1.03-1.16] | 1.08 [1.00-1.16] |
End-of-SRT PSA | 1.15 [1.06-1.24] | 1.26 [1.12-1.40] |
PTEN loss | ||
Heterogeneous | 1.34 [0.79-2.26] | 0.90 [0.33-2.47] |
Homogeneous | 1.73 [1.06-2.82] | 2.35 [1.04-5.34] |
ERG expression | 1.15 [0.77-1.73] | 1.21 [0.53-2.75] |
p53 mutation | 1.25 [0.62-2.52] | 0.81 [0.32-2.06] |
Emerson Lee, MD, BS
Johns Hopkins University
Baltimore, MD